- Home
- CMPX vs LFCR Comparison
CMPX vs LFCR Comparison
Compare CMPX & LFCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMPX
- LFCR
- Stock Information
- Founded
- CMPX 2014
- LFCR 1986
- Country
- CMPX United States
- LFCR United States
- Employees
- CMPX N/A
- LFCR N/A
- Industry
- CMPX Biotechnology: Pharmaceutical Preparations
- LFCR Biotechnology: Pharmaceutical Preparations
- Sector
- CMPX Health Care
- LFCR Health Care
- Exchange
- CMPX Nasdaq
- LFCR Nasdaq
- Market Cap
- CMPX 214.6M
- LFCR 218.8M
- IPO Year
- CMPX N/A
- LFCR N/A
- Fundamental
- Price
- CMPX $2.92
- LFCR $5.61
- Analyst Decision
- CMPX Strong Buy
- LFCR Buy
- Analyst Count
- CMPX 6
- LFCR 3
- Target Price
- CMPX $12.50
- LFCR $8.00
- AVG Volume (30 Days)
- CMPX 1.4M
- LFCR 127.0K
- Earning Date
- CMPX 03-20-2025
- LFCR 01-02-2025
- Dividend Yield
- CMPX N/A
- LFCR N/A
- EPS Growth
- CMPX N/A
- LFCR N/A
- EPS
- CMPX N/A
- LFCR N/A
- Revenue
- CMPX $850,000.00
- LFCR $130,858,000.00
- Revenue This Year
- CMPX N/A
- LFCR $2.24
- Revenue Next Year
- CMPX $613.39
- LFCR $7.88
- P/E Ratio
- CMPX N/A
- LFCR N/A
- Revenue Growth
- CMPX N/A
- LFCR 16.47
- 52 Week Low
- CMPX $0.77
- LFCR $3.68
- 52 Week High
- CMPX $4.08
- LFCR $8.45
- Technical
- Relative Strength Index (RSI)
- CMPX 48.30
- LFCR 38.75
- Support Level
- CMPX $3.14
- LFCR $5.59
- Resistance Level
- CMPX $3.85
- LFCR $6.39
- Average True Range (ATR)
- CMPX 0.33
- LFCR 0.29
- MACD
- CMPX -0.11
- LFCR 0.01
- Stochastic Oscillator
- CMPX 5.68
- LFCR 2.50
About CMPX Compass Therapeutics Inc.
Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics intended to engage the immune system to treat both solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to broadly drug the immune system and identify optimal combinations empirically. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of three product candidates, CTX-009, CTX-471, and CTX-8371.
About LFCR Lifecore Biomedical Inc.
Lifecore Biomedical Inc is a fully integrated contract development and manufacturing organization (CDMO) that offers differentiated capabilities in the development, filling, and finishing of complex sterile injectable pharmaceutical products in syringes and vials. It manufactures injectable-grade Hyaluronic Acid. Lifecore recognizes revenue in two different product categories, CDMO and fermentation.